25 Facts About Sangeeta Bhatia

Sangeeta Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration.

Sangeeta Bhatia's applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.

Sangeeta Bhatia's was named a "Scientist to Watch" by The Scientist in 2006.

Sangeeta Bhatia's has received multiple awards and has been elected to the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors.

Sangeeta Bhatia's dissertation became the basis for Microfabrication in tissue engineering and bioartificial organs .

Related searches

Sangeeta Bhatia co-authored the first undergraduate textbook on tissue engineering, Tissue engineering, written for senior-level and first-year graduate courses with Bernhard Palsson.

Sangeeta Bhatia's was a co-editor of Microdevices in Biology and Medicine and Biosensing: International Research and Development .

Sangeeta Bhatia's parents emigrated from India to Boston, Massachusetts; her father was an engineer and her mother was one of the first women to receive an MBA in India.

Sangeeta Bhatia was motivated to become an engineer after her 10th grade biology class and a trip with her father into an MIT lab to see a demonstration of an ultrasound machine for cancer treatment.

Sangeeta Bhatia studied bioengineering at Brown University where she joined a research group studying artificial organs which convinced her to pursue graduate study the field.

Sangeeta Bhatia joined the faculty at the University of California, San Diego in 1998.

Sangeeta Bhatia's was named a 2001 "Teacher of the Year" in the Bioengineering Department at the Jacobs School of Engineering, and was named an Innovator under 35 by MIT Technology Review in 2003.

Sangeeta Bhatia was named a "Scientist to Watch" by The Scientist in 2006 and became a Howard Hughes Medical Institute investigator in 2008.

Sangeeta Bhatia currently directs the Laboratory for Multiscale Regenerative Technologies at MIT and is affiliated with Brigham and Women's Hospital and the Koch Institute for Integrative Cancer Research.

Sangeeta Bhatia is a strong advocate for gender equity and inclusivity in STEM fields.

Sangeeta Bhatia helped to found the Diversity Committee of the Biomedical Engineering Society, and is involved with MIT's Society of Women Engineers.

In 2015, Sangeeta Bhatia was elected a member of the National Academy of Engineering for tissue engineering and tissue regeneration technologies, stem cell differentiation, and preclinical drug evaluation.

Sangeeta Bhatia's adapted ideas from computer chip design and engineering to the microfabrication of a substrate for liver cells.

Sangeeta Bhatia's successfully applied techniques from photolithography to petri dishes, to create a substrate that would support growth of a functioning microliver in a dish.

Sangeeta Bhatia used co-cultures of more than one cell type to prevent dedifferentiation of the liver cells, building on the work of Christiane Guguen-Guillouzo in France.

Sangeeta Bhatia's is interested in using arrays of living cells as high-throughput platforms to study fundamental aspects of Bio-MEMS in stem cells.

Sangeeta Bhatia's laboratory is involved in a multidisciplinary effort to develop nanomaterials as tools for biological studies and as multifunctional agents for cancer therapies.

In 2002, Sangeeta Bhatia worked with Erkki Ruoslahti and Warren Chan to develop phage-derived peptide-targeted nanomaterials, or quantum dots, for in vivo targeting of tumors.

Sangeeta Bhatia holds a number of patents for both clinical and biotechnological applications of engineering principles.

Sangeeta Bhatia is the recipient of a number of awards and honors including the following:.

Related searches